The company announced last week it had signed a 5-year distribution agreement with Medizin for LGP’s medical cannabis oils and flower products in Poland.
Back in February 2020, the company entered into a purchase agreement with Germany’s Demacan for up to 1,000kg of LGP products annually over a three year term.
While LGP said there isn’t any reason not to expect it in the near term, if Demacan doesn’t receive the approval before the end of the June quarter LGP will instead package this product for Australia, where LGP can generate more revenue from it.